Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Instituto do Câncer e Transplante de Curitiba (Site 0102)

Curitiba, Paraná 80510-130, BrazilNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Kidney cancer

Running trials

Active, not recruiting
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)
NCT05239728· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Instituto do Câncer e Transplante de Curitiba (Site 0102): trial site – Frontlight Research